Abstract: SA-PO130
Onconephrology, an Essential Subspecialty: Experience of a University Hospital Center
Session Information
- Onconephrology: Clinical and Research Advances - II
November 05, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
Abstract Time: 10:00 AM - 12:00 PM
Category: Onconephrology
- 1600 Onconephrology
Authors
- Bermejo, Sheila, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain
- Bolufer, Mónica, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain
- Viggiano, Davide, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy
- Callejo, Ana, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain
- López-Martínez, Marina, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain
- Vergara, Ander, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain
- Agraz, Irene, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain
- Bestard, Oriol, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain
- Soler, Maria Jose, Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain
Background
Kidney complications of cancer patients and cancer in renal patients have increased in recent years. This study evaluates the characteristics of the patients referred to the Onco-Nephrology Unit from January 2021 to December 2021, studying the cognitive and mood status of these patients.
Methods
This is a prospective observational study of the Onco-Nephrology consultation at our hospital during 2021. Clinical and analytical characteristics of the patients and clinical indication for referral were analyzed. In addition, sleep quality, mood and cognitive status were assessed using validated rating scales(Epsworth, Geriatric Depression Scale and Montreal).
Results
Seventy-four patients were evaluated, mean age was 69.6(±11) years, 41(55.4%) men, 47(63.5%) had hypertension, 18(24.3%) diabetics, and 11(14.9%) were affected by heart disease. In addition, creatinine 1.93(±1.1)mg/dl, eGFR 39.97(±20.3)mL/min, proteinuria 187[29-515.9]mg/g, and 4(5.4%) had microhematuria. The most frequent cancers were intestinal, gynecological and mammary with 12.16%(n=9) each. 58.3%(n=42) of patients had metastatic disease. 48.7%(n=36) received chemotherapy and 58.1%(n=43) targeted therapies. Platinum was the most frequently used chemotherapy and anti-VEGF in terms of targeted therapies. The most frequent clinical indication for referral was acute renal failure(n=36;48.7%). Rating scales were obtained in 51 patients: 49%(n=25) were snorers, followed by 17.6%(n=9) with insomnia and 11.8%(n=6) with OSAS. 27 patients(36.5%) had cognitive impairment. Mild depression was detected in 13 cases(25.5%) and moderate depression in 11.6%(n=6). 21 renal biopsies were performed, the most frequent diagnosis was acute interstitial nephritis(71.4%, n=15) followed by thrombotic microangiopathy(19% n=4).A total of 15 patients(20.3%) died during the year.
Conclusion
Most patients referred to Onco-Nephrology are affected by advanced oncological disease and consequently had a high mortality.The most frequent indication for referral was acute kidney injury(48.7%). Comprehensive patient care is important, given the prevalence of depressive syndrome.Onco-Nephrology is an example of a comprehensive and multidisciplinary approach to improve the survival and quality of life of patients with advanced cancer and renal disease.